Enhanced Production of Recombinant Extractable Antigen (EA1) an Extracellular Protein and its use in Detection of Spores of Bacillus anthracis the Causative Agent of Anthrax

Detection of spores of Bacillus anthracis, the causative agent of anthrax in human and animals in environment is cumbersome due to the presence of spores of other closely related Bacillus species. The Extractable Antigen 1 (EA1), an extracellular protein is considered as a biomarker for detection of B. anthracis spores. In the present work, we have cloned and expressed the recombinant EA1 protein in soluble form in Escherichia coli. Optimisation of culture conditions and cultivation media was carried out to achieve enhanced soluble expression of recombinant EA1 protein. Further, the batch fermentation process was also developed using optimised conditions for scale up production of recombinant EA1 protein. The final yield of protein purified employing affinity chromatography was 42.64 mg/l of culture during batch fermentation process. The polyclonal antibodies were raised against recombinant EA in rabbit and mice and used to develop an ELISA for detection of B. anthracis spores. The specificity of the developed assay was ascertained with spores of other Bacillus species. The results corroborated that the EA1 could be a suitable biomarker for detection of B. anthracis spores

Production and Purification of Protective Antigen of Bacillus anthracis and Development of a Sandwich ELISA for its Detection

Anthrax, a zoonotic disease caused by Bacillus anthracis is important for biowarfare as well as public health point of view. The virulence factors of B. anthracis are encoded by the two plasmids, pXO1 and pXO2. Protective antigen (PA), an 83 kDa protein encoded by pXO1 along with lethal factor (LF, 90 kDa) or edema factor (EF, 89 kDa), makes the anthrax toxin responsible for causing the disease. Current detection and diagnostic systems for anthrax are mostly based on PA, a potential biomarker of B. anthracis. The objective of the present study was to produce and purify the PA for development of a sandwich ELISA for its detection. In this study, pYS5 plasmid containing the full PA gene was transformed into an 8 proteases deficient Bacillus anthracis host BH480. The PA was produced under shake flask conditions and purified using the gel filtration chromatography. The reactivity of PA with rabbit and mouse anti-PA antibodies was confirmed by Western blotting. The antibodies were purified and used for the development of a sandwich ELISA for detection of PA. The detection sensitivity of ELISA was found to be 3.9 ng/ mL PA

Iso-conversional study of crystallization activation energy of amorphous-crystallization transformation for Se79Te20Pb1 glass using non-isothermal differential scanning calorimetry technique

135-140The ternary Se79Te20Pb1 chalcogenide glass is prepared using melt quenching technique. Differential scanning calorimetry technique (DSC) is used to investigate the kinetics of crystallization of amorphous-crystallization (a-c) phase transformation under non-isothermal conditions at three different heating rates; 5, 10 and 15° C min-1. The variation of crystallized activation energy (Ec) with crystallized fraction (ϰ) and hence, with temperature (T) is investigated using five iso-conversional methods namely KAS, OFW, Friedman, Tang and Chen and Starink. It is found that Ec is not constant but vary with ϰ as well as T. Thus, the iso-conversional analysis of investigated glass indicates that the assumption of constant Ec is not appropriate

Iso-conversional study of crystallization activation energy of amorphous-crystallization transformation for Se79Te20Pb1 glass using non-isothermal differential scanning calorimetry technique

The ternary Se79Te20Pb1 chalcogenide glass is prepared using melt quenching technique. Differential scanning calorimetry technique (DSC) is used to investigate the kinetics of crystallization of amorphous-crystallization (a-c) phase transformation under non-isothermal conditions at three different heating rates; 5, 10 and 15° C min-1. The variation of crystallized activation energy (Ec) with crystallized fraction (ϰ) and hence, with temperature (T) is investigated using five iso-conversional methods namely KAS, OFW, Friedman, Tang and Chen and Starink. It is found that Ec is not constant but vary with ϰ as well as T. Thus, the iso-conversional analysis of investigated glass indicates that the assumption of constant Ec is not appropriat

Activated Carbon Fabric: An Adsorbent Material for Chemical Protective Clothing

Activated carbon fabric or fiber (ACF) is a novel carbonaceous material with exceptionally high adsorption rate and larger adsorption capacity, that has emerged as a rising star in the field of adsorbents. ACF has many advantages over other commercial porous storage materials such as granular activated carbon and powdered activated carbon in terms of adsorption capacity, well defined microporous structure, stability, flexibility and ease of lamination to various substrates. In the last few years, activated carbon fabrics have gained greater choice of interest for use as an adsorbent material in several fields including nuclear, biological and chemical (NBC) protection suit. Viscose rayon, acetate, polyacrylonitrile, pitch, and phenolic based materials are mainly used as precursors for preparation of ACF. ACF or fibres are generally prepared by process comprising stabilisation, carbonisation and activation of precursors. Reviews recent advances and developments in the field of ACF and their utility as an adsorbent material in various fields including NBC scenario. ACF with unmatchable pore structure and surface characteristics at present, with continued innovations and attention to its key challenges, it is expected that ACF will play a pivotal role in diverse environmental, defence, and civil applications

Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence

Cellular senescence is one of the prevailing issues in cancer therapeutics that promotes cancer relapse, chemoresistance, and recurrence. Patients undergoing persistent chemotherapy often develop drug-induced senescence. Docetaxel, an FDA-approved treatment for prostate cancer, is known to induce cellular senescence which often limits the overall survival of patients. Strategic therapies that counter the cellular and drug-induced senescence are an unmet clinical need. Towards this an effort was made to develop a novel therapeutic strategy that targets and removes senescent cells from the tumors, we developed a nanoformulation of tannic acid−docetaxel self-assemblies (DSAs). The construction of DSAs was confirmed through particle size measurements, spectroscopy, thermal, and biocompatibility studies. This formulation exhibited enhanced in vitro therapeutic activity in various biological functional assays with respect to native docetaxel treatments. Microarray and immunoblot analysis results demonstrated that DSAs exposure selectively deregulated senescence associated TGFβR1/FOXO1/p21 signaling. Decrease in β-galactosidase staining further suggested reversion of drug-induced senescence after DSAs exposure. Additionally, DSAs induced profound cell death by activation of apoptotic signaling through bypassing senescence. Furthermore, in vivo and ex vivo imaging analysis demonstrated the tumor targeting behavior of DSAs in mice bearing PC-3 xenograft tumors. The antisenescence and anticancer activity of DSAs was further shown in vivo by inhibiting TGFβR1 proteins and regressing tumor growth through apoptotic induction in the PC-3 xenograft mouse model. Overall, DSAs exhibited such advanced features due to a natural compound in the formulation as a matrix/binder for docetaxel. Overall, DSAs showed superior tumor targeting and improved cellular internalization, promoting docetaxel efficacy. These findings may have great implications in prostate cancer therapy

Japanese Encephalitis Outbreak, India, 2005

An outbreak of viral encephalitis occurred in Gorakhpur, India, from July through November 2005. The etiologic agent was confirmed to be Japanese encephalitis virus by analyzing 326 acute-phase clinical specimens for virus-specific antibodies and viral RNA and by virus isolation. Phylogenetic analysis showed that these isolates belonged to genogroup 3

Chemical Protection Studies of Activated Carbon Spheres based Permeable Protective Clothing Against Sulfur Mustard, a Chemical Warfare Agent

Technological advancements in the field of chemical threat have made it possible to create extremely dangerous chemical warfare agents (CWA). Hence, the effective protection of personnel is very important in a chemical warfare scenario amidst the current climate of terrorism awareness. In particular, body protection plays a substantial role in the chemical defence considering the urgency of situation in the nuclear, biological and chemical environment. Activated carbon spheres (ACS) based permeable chemical protective clothing (coverall) was developed for protection against CWA. The adsorbent material i.e, ACS used in this protective clothing provided higher adsorption capacity (1029 mg/g in terms of iodine) and low thermal burden (34 °C WBGT index) compared to earlier indigenously developed NBC suit. This article focuses on the extensive evaluation of chemical protective clothing against sulfur mustard (HD), a CWA. The results revealed that the developed protective clothing provided more than 24 h protection against HD. This chemical protective suit is light weight (< 2.75 kg for XL size). It also has higher air permeability (> 30 cm3/s/cm2) as well as less water vapour resistance (< 9.6 m2Pa/W). With continued innovations in materials and attention to key challenges it is expected that advanced, multifunction chemical protective suit will play a pivotal role in the CWA protection scenario

Porous carbon spheres: Recent developments and applications

Activated or porous carbon is a carbonaceous material which has excellent adsorption capacity. Activated carbon has many applications including heavy metal and toxic gas removal as well as air and water filter applications. Microporous activated carbon in spherical shape (activated or porous carbon spheres) is a variant of activated carbon which has high compressive strength and low ash content. Pitch, polymeric (phenolic and sulfonated polystyrene resins) and other precursor materials (carbohydrate and seeds) have been generally used for production of activated carbon spheres employing carbonization and activation processes. Various parameters viz. carbonization temperature, heating rate, activation time and temperature, and activation media affected the performance and quality of end product. Generally activation by physical and chemical means is used for activated carbon spheres preparation. The use of polymeric precursors yielded better compressive strength and minimal ash content in comparison to other precursors. Activated carbon spheres produced using these processes has been successfully utilized as adsorbent materials for removal of heavy metals, organic dye, carbon dioxide, volatile organic chemicals, support for catalyst, gas and energy storage and also in chemical protective clothings. In present review, we discuss latest developments in activated carbon spheres and its use as adsorbent materials for removal of toxicants and various other applications

Recent Developments in Recombinant Protein–Based Dengue Vaccines

Recombinant proteins are gaining enormous importance these days due to their wide application as biopharmaceutical products and proven safety record. Various recombinant proteins of therapeutic and prophylactic importance have been successfully produced in microbial and higher expression host systems. Since there is no specific antiviral therapy available against dengue, the prevention by vaccination is the mainstay in reducing the disease burden. Therefore, efficacious vaccines are needed to control the spread of dengue worldwide. Dengue is an emerging viral disease caused by any of dengue virus 1–4 serotypes that affects the human population around the globe. Dengue virus is a single stranded RNA virus encoding three structural proteins (capsid protein, pre-membrane protein, and envelope protein) and seven non-structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, NS5). As the only licensed dengue vaccine (Dengvaxia) is unable to confer balanced protection against all the serotypes, therefore various approaches for development of dengue vaccines including tetravalent live attenuated, inactivated, plasmid DNA, virus-vectored, virus-like particles, and recombinant subunit vaccines are being explored. These candidates are at different stages of vaccine development and have their own merits and demerits. The promising subunit vaccines are mainly based on envelope or its domain and non-structural proteins of dengue virus. These proteins have been produced in different hosts and are being investigated for development of a successful dengue vaccine. Novel immunogens have been designed employing various strategies like protein engineering and fusion of antigen with various immunostimulatory motif to work as self-adjuvant. Moreover, recombinant proteins can be formulated with novel adjuvants to enhance the immunogenicity and thus conferring better protection to the vaccinees. With the advent of newer and safer host systems, these recombinant proteins can be produced in a cost effective manner at large scale for vaccine studies. In this review, we summarize recent developments in recombinant protein based dengue vaccines that could lead to a good number of efficacious vaccine candidates for future human use and ultimately alternative dengue vaccine candidates